To evaluate the efficacy of Z-338 [acotiamide] in subjects with functional dyspepsia, focusing on the assessment of subjective symptoms
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2016
At a glance
- Drugs Acotiamide (Primary)
- Indications Non-ulcer dyspepsia
- Focus Therapeutic Use
- Sponsors Zeria
- 26 Apr 2008 Status changed from in progress to completed.
- 01 Dec 2006 Status change
- 29 Sep 2006 New trial record.